Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany
Thursday, May 07, 2026Vertex Pharmaceuticals Incorporated announced today that a reimbursement agreement was signed with the GKVSpitzenverband for its CRISPRCas geneedited therapy CASGEVY exagamglogene autotemcel This agreement secures sustainable access to this innovativ...
Waiv Enters Collaboration with Daiichi Sankyo to Deliver AI-Derived Biomarkers for ADC Program
Thursday, May 07, 2026Waiv formerly Owkin Dx a Parisbased company catalyzing AI precision testing today announced it has entered a collaboration with Daiichi Sankyo TSE to lead digital pathology biomarker discovery for an antibodydrug conjugate ADC program
Cartography Biosciences Announces Strategic Investment From Samsung Ventures to Advance Oncology Pipeline
Thursday, May 07, 2026Cartography Biosciences and Samsung Ventures today announced a strategic investment to support the advancement of Cartographys differentiated oncology pipeline and expand its proprietary drug discovery platform
Taimei Technology and C&R Research Announce Strategic Partnership to Build AI-Powered Clinical Trial Innovation
Thursday, May 07, 2026Taimei Technology HK a leading AIpowered drug clinical development platform company and CR Research A a toptier CRO in South Korea signed an enterpriselevel strategic partnership agreement
Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
Tuesday, April 21, 2026Merck a leading science and technology company today announced the launch of the first biobased solvent portfolio specifically for highperformance liquid chromatography HPLC Manufactured using renewable feedstocks these new patentpending solvents del...
INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases
Wednesday, May 06, 2026INmune Bio Inc a clinicalstage biotechnology company and Anthony Nolan a pioneering UKbased charity that set up the worlds first stem cell register and is now driving forward cell therapy advancements
Cleveland Clinic, RIKEN, and IBM Model a 12,635-Atom Protein - the Largest Known to Be Simulated with Quantum Computers
Wednesday, May 06, 2026Scientists at Cleveland Clinic RIKEN and IBM NYSE IBM have used IBM quantum computers and two of the worlds most powerful supercomputers to simulate protein complexes spanning up to atoms
Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)
Tuesday, May 05, 2026Cellenkos Inc a clinical stage biotechnology company pioneering allogeneic tissuetargeted regulatory T cell Treg therapies today announced that the US Food and Drug Administration FDA has cleared its Investigational
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
Friday, May 01, 2026Shanghai Henlius Biotech Inc HK and Organon NYSE OGN today announced the European Commission EC has granted marketing authorization for POHERDY pertuzumab mg mL injection for intravenous use
Ecolab Life Sciences Expands Global Bioprocessing Capabilities With New Advanced Development and Applications Center in Korea
Thursday, April 30, 2026Building on the continued growth and strong performance of its Life Sciences business Ecolab is further expanding its global bioprocessing capabilities to support biopharmaceutical manufacturers worldwide
